Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

owens & minor inc. - OMI

OMI

Close Chg Chg %
12.24 0.10 0.78%

Closed Market

12.33

+0.10 (0.78%)

Volume: 521.03K

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: owens & minor inc. - OMI

OMI Key Data

Open

$12.25

 Day Range

12.05 - 12.62

52 Week Range

11.42 - 28.34

 Market Cap

$943.04M

Shares Outstanding

77.11M

 Public Float

69.90M

Beta

0.41

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.64

Yield

0.00%

 Dividend

$0.00

EX-DIVIDEND DATE

Dec 14, 2021

 SHORT INTEREST

N/A

AVERAGE VOLUME

814.85K

  

OMI Performance

1 Week
 
 0.73%
 
1 Month
 
 -7.90%
 
3 Months
 
 -24.56%
 
1 Year
 
 -34.69%
 
5 Years
 
 95.72%
 

OMI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About owens & minor inc. - OMI

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

OMI At a Glance

Owens & Minor, Inc.
9120 Lockwood Boulevard
Mechanicsville, Virginia 23116-2015
Phone 1-804-723-7000 Revenue 10.33B
Industry Medical Specialties Net Income -41,301,000.00
Sector Health Technology 2023 Sales Growth 3.802%
Fiscal Year-end 12 / 2024 Employees 22,200
View SEC Filings

OMI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.141
Price to Book Ratio 1.596
Price to Cash Flow Ratio 1.972
Enterprise Value to EBITDA 7.221
Enterprise Value to Sales 0.348
Total Debt to Enterprise Value 0.67

OMI Efficiency

Revenue/Employee 465,494.009
Income Per Employee -1,860.405
Receivables Turnover 17.273
Total Asset Turnover 1.972

OMI Liquidity

Current Ratio 1.111
Quick Ratio 0.524
Cash Ratio 0.144

OMI Profitability

Gross Margin 17.784
Operating Margin 2.038
Pretax Margin -0.53
Net Margin -0.40
Return on Assets -0.788
Return on Equity -4.418
Return on Total Capital -1.239
Return on Invested Capital -1.236

OMI Capital Structure

Total Debt to Total Equity 260.604
Total Debt to Total Capital 72.269
Total Debt to Total Assets 47.286
Long-Term Debt to Equity 228.641
Long-Term Debt to Total Capital 63.405
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Owens & Minor Inc. - OMI

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
8.48B 9.79B 9.96B 10.33B
Sales Growth
-7.93% +15.39% +1.74% +3.80%
Cost of Goods Sold (COGS) incl D&A
7.29B 8.36B 8.36B 8.50B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
93.34M 90.62M 228.67M 287.38M
Depreciation
41.65M 40.51M 135.82M 170.24M
Amortization of Intangibles
51.69M 50.11M 92.85M 117.14M
COGS Growth
-10.84% +14.67% -0.06% +1.66%
Gross Income
1.19B 1.42B 1.60B 1.84B
Gross Income Growth
+15.15% +19.80% +12.31% +15.03%
Gross Profit Margin
+14.00% +14.54% +16.05% +17.78%
2020 2021 2022 2023 5-year trend
SG&A Expense
948.00M 1.03B 1.41B 1.63B
Research & Development
- - - -
-
Other SG&A
948.00M 1.03B 1.41B 1.63B
SGA Growth
+2.34% +8.25% +36.91% +15.82%
Other Operating Expense
- - - -
-
Unusual Expense
37.75M 48.99M 55.02M 95.61M
EBIT after Unusual Expense
201.75M 347.37M 137.66M 114.96M
Non Operating Income/Expense
(17.67M) (22.52M) 1.47M (2.05M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
74.17M 48.09M 128.24M 167.63M
Interest Expense Growth
-22.49% -35.16% +166.67% +30.72%
Gross Interest Expense
74.17M 48.09M 128.24M 167.63M
Interest Capitalized
- - - -
-
Pretax Income
109.91M 276.75M 10.89M (54.73M)
Pretax Income Growth
+482.70% +151.81% -96.06% -602.49%
Pretax Margin
+1.30% +2.83% +0.11% -0.53%
Income Tax
21.83M 55.16M (11.50M) (13.43M)
Income Tax - Current - Domestic
2.10M 70.05M 6.21M 5.42M
Income Tax - Current - Foreign
4.17M 14.85M 8.65M 4.89M
Income Tax - Deferred - Domestic
15.38M (26.22M) (14.07M) (22.90M)
Income Tax - Deferred - Foreign
185.00K (3.52M) (12.29M) (829.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
88.07M 221.59M 22.39M (41.30M)
Minority Interest Expense
- - - -
-
Net Income
88.07M 221.59M 22.39M (41.30M)
Net Income Growth
+489.98% +151.59% -89.90% -284.47%
Net Margin Growth
+1.04% +2.26% +0.22% -0.40%
Extraordinaries & Discontinued Operations
- - - (58.20M)
-
Discontinued Operations
- - - (58.20M)
-
Net Income After Extraordinaries
29.87M 221.59M 22.39M (41.30M)
Preferred Dividends
- - - -
-
Net Income Available to Common
29.87M 221.59M 22.39M (41.30M)
EPS (Basic)
0.4714 3.0462 0.3005 -0.545
EPS (Basic) Growth
+145.78% +546.20% -90.14% -281.36%
Basic Shares Outstanding
63.37M 72.74M 74.50M 75.78M
EPS (Diluted)
0.4703 2.9355 0.2938 -0.545
EPS (Diluted) Growth
+145.67% +524.18% -89.99% -285.50%
Diluted Shares Outstanding
63.51M 75.49M 76.22M 75.78M
EBITDA
332.83M 486.98M 421.35M 497.94M
EBITDA Growth
+65.05% +46.31% -13.48% +18.18%
EBITDA Margin
+3.92% +4.98% +4.23% +4.82%

Snapshot

Average Recommendation HOLD Average Target Price 16.929
Number of Ratings 7 Current Quarters Estimate 0.542
FY Report Date 12 / 2024 Current Year's Estimate 1.524
Last Quarter’s Earnings 0.42 Median PE on CY Estimate N/A
Year Ago Earnings 1.36 Next Fiscal Year Estimate 1.853
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 4 7 7
Mean Estimate 0.54 0.25 1.52 1.85
High Estimates 0.65 0.29 1.67 2.08
Low Estimate 0.50 0.22 1.48 1.75
Coefficient of Variance 9.63 12.68 4.45 6.19

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 1 1 1
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Owens & Minor Inc. - OMI

Date Name Shares Transaction Value
Jul 4, 2024 Jonathan A. Leon SVP, Corporate Treasurer 100,671 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Michael Wayne Lowry SVP, Corporate Controller 96,347 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 7, 2024 Mark A. Beck Director 11,154 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.25 per share 192,406.50
Jun 6, 2024 Snehashish Sarkar EVP, Chief Information Officer 59,137 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.32 per share 1,024,252.84
Jun 5, 2024 Alexander J. Bruni EVP, CFO 49,950 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.76 per share 887,112.00
Jun 5, 2024 Jennifer Stone EVP, CHRO 57,078 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Edward A. Pesicka President & CEO; Director 754,066 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.78 per share 14,915,425.48
May 17, 2024 Daniel J. Starck EVP, Business Excellence 95,612 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.78 per share 1,891,205.36
May 17, 2024 Perry A. Bernocchi EVP, CEO,. Patient Direct 149,535 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.78 per share 2,957,802.30
May 17, 2024 Andrew G. Long EVP, CEO P&HS 222,408 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.78 per share 4,399,230.24
May 17, 2024 Heath H. Galloway EVP,General Counsel & CorpSecy 58,929 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.78 per share 1,165,615.62
May 6, 2024 Perry A. Bernocchi EVP, CEO,. Patient Direct 170,497 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.27 per share 4,137,962.19
Feb 9, 2024 Heath H. Galloway EVP,General Counsel & CorpSecy 36,330 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.96 per share 725,146.80

Owens & Minor Inc. in the News